NLRP3 and metabolic dysfunction-associated steatotic liver disease: Studies suggest a significant role of NLRP3 inflammasome in the initiation and progression of metaflammation (i.e., metabolically-induced inflammation) and related diseases, such as obesity, T2DM, NAFLD, and atherosclerosis15–17.